Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on December 2, 2025

Dec. 2, 2025

Syrian-American Entrepreneurs and Syrian Government Launch Fintech Revolution to Rebuild Nation

EIN Presswire

Dec. 2, 2025

Syndesis Health and Lifenome Partner to Accelerate Global Adoption of Precision Health and Longevity Medicine

EIN Presswire

Dec. 2, 2025

Ramakanth Evani Wins at the 2025 NY Product Design Awards: Season 2 for The VitaPod – AI

EIN Presswire

Dec. 2, 2025

Covercy and NAV Fund Services Announce Strategic Partnership to Deliver Comprehensive Fund Administration Solutions

EIN Presswire

Dec. 2, 2025

Quartz Partners Investment Management Appoints Joe Nassar as Vice President of Business Development

EIN Presswire

Dec. 2, 2025

Flychain and Office Puzzle Announce Partnership to Help Medicaid ABA Providers With Operational and Financial Support

EIN Presswire

Dec. 2, 2025

Scratch-Off Hub Launches as the First Completely Free, Data-Driven Resource for U.S. Scratch-Off Ticket Lottery Insights

EIN Presswire

Dec. 2, 2025

Currence Launches Cash Flow Simulator, the First Onboarding Tool Built to Support the IUM™ Planning Model

EIN Presswire

Dec. 2, 2025

DXCM DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

GlobeNewswire

Dec. 2, 2025

CPTN DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Cepton, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CPTN

GlobeNewswire

Dec. 2, 2025

Clene to Provide CNM-Au8® ALS Program Update

GlobeNewswire

Dec. 2, 2025

Bragar Eagel & Squire, P.C. Reminds Investors of Telix, Freeport, and Primo Brands to Contact the Firm About their Rights Before Lead Plaintiff Deadlines

GlobeNewswire

Dec. 2, 2025

Bragar Eagel & Squire, P.C. Urges Investors of Cepton, and MoonLake to Inquire About Their Rights Before Upcoming Deadlines

GlobeNewswire

Dec. 2, 2025

ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure

GlobeNewswire

Dec. 2, 2025

MLTX Lawsuit: Hagens Berman Scrutinizing MoonLake’s SLK Efficacy Claims After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority

GlobeNewswire

Dec. 2, 2025

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

$Conflicting Guidance and Rapid Innovation Leave Physicians Seeking Clarity in Relapsed/Refractory Multiple Myeloma$

Dec. 2, 2025

Conflicting Guidance and Rapid Innovation Leave Physicians Seeking Clarity in Relapsed/Refractory Multiple Myeloma

GlobeNewswire

Dec. 2, 2025

Foot Renew Unveiled: How The RejuvaCare FootRenew Massager Eases Neuropathy Pain & Boosts Foot Circulation

GlobeNewswire

Dec. 2, 2025

New Data Presented at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF

GlobeNewswire

Dec. 2, 2025

Check Point Software Announces Proposed Private Offering of $1.5 Billion of 0.00% Convertible Senior Notes due 2030

GlobeNewswire